PROK PROKIDNEY CORP Expansion Plans 8-K Filing 2025 - Market Expansion On July 15, 2025, ProKidney Corp. announced that it has aligned with the U.S. FDA on the accelerated approval pathway for its treatment, rilparencel.Get access to all SEC 8-K filings of the PROKIDNEY CORP